PHK
SAGE

Point72 Hong Kong’s Sage Therapeutics SAGE Stock Holding History

Point72 Hong Kong’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,325
Closed -$62.3K – 689
2024
Q1 		$62.3K Sell
3,325
-7,609
-70% -$176K ﹤0.01% 447
2023
Q4 		$237K Buy
+10,934
New +$217K 0.01% 419
2022
Q3 		– Sell
-9,927
Closed -$321K – 2363
2022
Q2 		$321K Buy
9,927
+1,176
+13% +$39.4K 0.01% 845
2022
Q1 		$290K Buy
8,751
+4,521
+107% +$170K 0.01% 850
2021
Q4 		$180K Sell
4,230
-448
-10% -$18.8K 0.01% 1036
2021
Q3 		$207K Buy
+4,678
New +$215K 0.01% 1159
2020
Q2 		– Sell
-412
Closed -$12K – 1391
2020
Q1 		$12K Sell
412
-988
-71% -$57.2K 0.01% 647
2019
Q4 		$101K Buy
1,400
+350
+33% +$43.1K 0.02% 513
2019
Q3 		$147K Buy
1,050
+808
+334% +$135K 0.04% 364
2019
Q2 		$44K Buy
+242
New +$41.3K 0.01% 653
2018
Q4 		– Sell
-603
Closed -$85K – 1163
2018
Q3 		$85K Buy
603
+416
+222% +$64.2K 0.03% 371
2018
Q2 		$29K Buy
+187
New +$29.4K 0.01% 528
2017
Q4 		– Sell
-67
Closed -$4K – 1058
2017
Q3 		$4K Buy
+67
New +$5.26K ﹤0.01% 596
2017
Q2 		– Sell
-613
Closed -$44K – 1006
2017
Q1 		$44K Buy
613
+606
+8,657% +$35.5K 0.06% 262
2016
Q4 		$0 Buy
+7
New +$330 ﹤0.01% 1020

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Point72 Hong Kong's SAGE Position: Q2 2024 in Review

Point72 Hong Kong sold out of Sage Therapeutics (SAGE) in Q2 2024, closing a stake of 3,325 shares — an estimated $62.3K sold.

Point72 Hong Kong first reported a position in SAGE in Q4 2016 and held it in 15 quarters. The position peaked at $321K in Q2 2022. 195 funds tracked by Wall St. Rank hold SAGE as of Q2 2024.

  • Point72 Hong Kong reported no remaining Sage Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 3,325 Sage Therapeutics shares in Q2 2024, an estimated $62.3K.
  • Point72 Hong Kong first reported a position in Sage Therapeutics in Q4 2016 and held it in 15 quarters.
  • Point72 Hong Kong's Sage Therapeutics position peaked at $321K in Q2 2022.
  • 195 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.